Retrospective clinical analyses underscore the prognostic significance of CXCR4, as its overexpression correlates with increased lymph node metastasis risk, including micrometastases (46, 47). The gene discussed is CXCR4; the disease is metastatic malignant neoplasm in the lymph nodes.